nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—ABCB1—melanoma	0.555	1	CbGaD
Lisinopril—ACE—umbilical vein—melanoma	0.0116	0.148	CbGeAlD
Lisinopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.0111	0.262	CbGpPWpGaD
Lisinopril—ACE—hindlimb—melanoma	0.0107	0.135	CbGeAlD
Lisinopril—ACE—arm—melanoma	0.0102	0.129	CbGeAlD
Lisinopril—ACE—appendage—melanoma	0.00914	0.116	CbGeAlD
Lisinopril—ACE—endothelium—melanoma	0.00552	0.0701	CbGeAlD
Lisinopril—ACE—blood vessel—melanoma	0.00509	0.0646	CbGeAlD
Lisinopril—ACE2—head—melanoma	0.0047	0.0597	CbGeAlD
Lisinopril—ACE—neck—melanoma	0.00364	0.0462	CbGeAlD
Lisinopril—ACE2—lymph node—melanoma	0.00329	0.0418	CbGeAlD
Lisinopril—SLC15A1—mammalian vulva—melanoma	0.003	0.0381	CbGeAlD
Lisinopril—ACE—eye—melanoma	0.00271	0.0344	CbGeAlD
Lisinopril—Fosinopril—SLC15A2—melanoma	0.00231	0.144	CrCbGaD
Lisinopril—ACE—mammalian vulva—melanoma	0.00215	0.0273	CbGeAlD
Lisinopril—Spirapril—SLC15A2—melanoma	0.00186	0.116	CrCbGaD
Lisinopril—ABCB1—blood vessel—melanoma	0.00179	0.0228	CbGeAlD
Lisinopril—Moexipril—SLC15A2—melanoma	0.00179	0.111	CrCbGaD
Lisinopril—Quinapril—SLC15A2—melanoma	0.00166	0.104	CrCbGaD
Lisinopril—Cilazapril—SLC15A2—melanoma	0.00166	0.104	CrCbGaD
Lisinopril—ACE2—Peptide hormone metabolism—PAX6—melanoma	0.00165	0.0389	CbGpPWpGaD
Lisinopril—Trandolapril—SLC15A2—melanoma	0.00161	0.1	CrCbGaD
Lisinopril—Ramipril—SLC15A2—melanoma	0.00161	0.1	CrCbGaD
Lisinopril—ACE—head—melanoma	0.00154	0.0195	CbGeAlD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.0015	0.0353	CbGpPWpGaD
Lisinopril—Benazepril—SLC15A2—melanoma	0.00145	0.0901	CrCbGaD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00144	0.034	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCB5—melanoma	0.00123	0.0291	CbGpPWpGaD
Lisinopril—ACE—lymph node—melanoma	0.00108	0.0137	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—PIGU—melanoma	0.00101	0.0239	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ADAMTS20—melanoma	0.00101	0.0239	CbGpPWpGaD
Lisinopril—ABCB1—retina—melanoma	0.000945	0.012	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—ARL2—melanoma	0.000928	0.0219	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.000881	0.0208	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.000848	0.02	CbGpPWpGaD
Lisinopril—Nateglinide—SLC15A2—melanoma	0.000833	0.0519	CrCbGaD
Lisinopril—ABCB1—mammalian vulva—melanoma	0.000756	0.00961	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—IGF1—melanoma	0.000749	0.0177	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—PAX6—melanoma	0.000735	0.0174	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—SLC17A5—melanoma	0.000677	0.016	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ADAMTS13—melanoma	0.000654	0.0154	CbGpPWpGaD
Lisinopril—Erythema multiforme—Temozolomide—melanoma	0.000625	0.00203	CcSEcCtD
Lisinopril—Tinnitus—Temozolomide—melanoma	0.000616	0.002	CcSEcCtD
Lisinopril—Malaise—Bleomycin—melanoma	0.000615	0.00199	CcSEcCtD
Lisinopril—Flushing—Temozolomide—melanoma	0.000613	0.00199	CcSEcCtD
Lisinopril—Arrhythmia—Carmustine—melanoma	0.000611	0.00198	CcSEcCtD
Lisinopril—Leukopenia—Bleomycin—melanoma	0.00061	0.00198	CcSEcCtD
Lisinopril—Dizziness—Vemurafenib—melanoma	0.000607	0.00197	CcSEcCtD
Lisinopril—Alopecia—Carmustine—melanoma	0.000604	0.00196	CcSEcCtD
Lisinopril—Angiopathy—Temozolomide—melanoma	0.000599	0.00194	CcSEcCtD
Lisinopril—Mental disorder—Carmustine—melanoma	0.000599	0.00194	CcSEcCtD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.000598	0.0141	CbGpPWpGaD
Lisinopril—Ataxia—Docetaxel—melanoma	0.000597	0.00194	CcSEcCtD
Lisinopril—Mediastinal disorder—Temozolomide—melanoma	0.000595	0.00193	CcSEcCtD
Lisinopril—Erythema—Carmustine—melanoma	0.000595	0.00193	CcSEcCtD
Lisinopril—Malnutrition—Carmustine—melanoma	0.000595	0.00193	CcSEcCtD
Lisinopril—Cough—Bleomycin—melanoma	0.000595	0.00193	CcSEcCtD
Lisinopril—Chills—Temozolomide—melanoma	0.000593	0.00192	CcSEcCtD
Lisinopril—Dehydration—Docetaxel—melanoma	0.000591	0.00192	CcSEcCtD
Lisinopril—Ill-defined disorder—Dactinomycin—melanoma	0.00059	0.00191	CcSEcCtD
Lisinopril—Anaemia—Dactinomycin—melanoma	0.000588	0.00191	CcSEcCtD
Lisinopril—Vomiting—Vemurafenib—melanoma	0.000584	0.00189	CcSEcCtD
Lisinopril—Alopecia—Temozolomide—melanoma	0.000584	0.00189	CcSEcCtD
Lisinopril—Chest pain—Bleomycin—melanoma	0.00058	0.00188	CcSEcCtD
Lisinopril—Myalgia—Bleomycin—melanoma	0.00058	0.00188	CcSEcCtD
Lisinopril—Orthostatic hypotension—Docetaxel—melanoma	0.00058	0.00188	CcSEcCtD
Lisinopril—Rash—Vemurafenib—melanoma	0.000579	0.00188	CcSEcCtD
Lisinopril—Mental disorder—Temozolomide—melanoma	0.000579	0.00188	CcSEcCtD
Lisinopril—Dermatitis—Vemurafenib—melanoma	0.000579	0.00188	CcSEcCtD
Lisinopril—Back pain—Carmustine—melanoma	0.000576	0.00187	CcSEcCtD
Lisinopril—Headache—Vemurafenib—melanoma	0.000575	0.00187	CcSEcCtD
Lisinopril—Erythema—Temozolomide—melanoma	0.000575	0.00187	CcSEcCtD
Lisinopril—Malnutrition—Temozolomide—melanoma	0.000575	0.00187	CcSEcCtD
Lisinopril—Breast disorder—Docetaxel—melanoma	0.000574	0.00186	CcSEcCtD
Lisinopril—Discomfort—Bleomycin—melanoma	0.000574	0.00186	CcSEcCtD
Lisinopril—Malaise—Dactinomycin—melanoma	0.000573	0.00186	CcSEcCtD
Lisinopril—Cramp muscle—Docetaxel—melanoma	0.000572	0.00185	CcSEcCtD
Lisinopril—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000572	0.00185	CcSEcCtD
Lisinopril—Leukopenia—Dactinomycin—melanoma	0.000569	0.00185	CcSEcCtD
Lisinopril—Nasopharyngitis—Docetaxel—melanoma	0.000568	0.00184	CcSEcCtD
Lisinopril—Dysgeusia—Temozolomide—melanoma	0.000563	0.00183	CcSEcCtD
Lisinopril—Confusional state—Bleomycin—melanoma	0.000561	0.00182	CcSEcCtD
Lisinopril—Vision blurred—Carmustine—melanoma	0.000561	0.00182	CcSEcCtD
Lisinopril—Tremor—Carmustine—melanoma	0.000558	0.00181	CcSEcCtD
Lisinopril—Anaphylactic shock—Bleomycin—melanoma	0.000556	0.0018	CcSEcCtD
Lisinopril—Oedema—Bleomycin—melanoma	0.000556	0.0018	CcSEcCtD
Lisinopril—Back pain—Temozolomide—melanoma	0.000556	0.0018	CcSEcCtD
Lisinopril—ACE2—Peptide hormone metabolism—CTNNB1—melanoma	0.000556	0.0131	CbGpPWpGaD
Lisinopril—Infection—Bleomycin—melanoma	0.000553	0.00179	CcSEcCtD
Lisinopril—Anaemia—Carmustine—melanoma	0.00055	0.00178	CcSEcCtD
Lisinopril—Nausea—Vemurafenib—melanoma	0.000546	0.00177	CcSEcCtD
Lisinopril—Thrombocytopenia—Bleomycin—melanoma	0.000545	0.00177	CcSEcCtD
Lisinopril—Vision blurred—Temozolomide—melanoma	0.000542	0.00176	CcSEcCtD
Lisinopril—Myalgia—Dactinomycin—melanoma	0.000541	0.00176	CcSEcCtD
Lisinopril—ABCB1—head—melanoma	0.000541	0.00687	CbGeAlD
Lisinopril—Bronchospasm—Docetaxel—melanoma	0.00054	0.00175	CcSEcCtD
Lisinopril—Tremor—Temozolomide—melanoma	0.000539	0.00175	CcSEcCtD
Lisinopril—Discomfort—Dactinomycin—melanoma	0.000535	0.00173	CcSEcCtD
Lisinopril—Angina pectoris—Docetaxel—melanoma	0.000535	0.00173	CcSEcCtD
Lisinopril—Ill-defined disorder—Temozolomide—melanoma	0.000534	0.00173	CcSEcCtD
Lisinopril—Leukopenia—Carmustine—melanoma	0.000533	0.00173	CcSEcCtD
Lisinopril—Anaemia—Temozolomide—melanoma	0.000532	0.00172	CcSEcCtD
Lisinopril—Anorexia—Bleomycin—melanoma	0.00053	0.00172	CcSEcCtD
Lisinopril—Angioedema—Temozolomide—melanoma	0.000526	0.0017	CcSEcCtD
Lisinopril—Pancytopenia—Docetaxel—melanoma	0.000521	0.00169	CcSEcCtD
Lisinopril—Hypotension—Bleomycin—melanoma	0.00052	0.00169	CcSEcCtD
Lisinopril—Oedema—Dactinomycin—melanoma	0.000519	0.00168	CcSEcCtD
Lisinopril—Malaise—Temozolomide—melanoma	0.000519	0.00168	CcSEcCtD
Lisinopril—Vertigo—Temozolomide—melanoma	0.000517	0.00168	CcSEcCtD
Lisinopril—Infection—Dactinomycin—melanoma	0.000516	0.00167	CcSEcCtD
Lisinopril—Leukopenia—Temozolomide—melanoma	0.000515	0.00167	CcSEcCtD
Lisinopril—Neutropenia—Docetaxel—melanoma	0.000513	0.00166	CcSEcCtD
Lisinopril—Palpitations—Temozolomide—melanoma	0.000508	0.00165	CcSEcCtD
Lisinopril—Thrombocytopenia—Dactinomycin—melanoma	0.000508	0.00165	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Bleomycin—melanoma	0.000507	0.00164	CcSEcCtD
Lisinopril—Myalgia—Carmustine—melanoma	0.000507	0.00164	CcSEcCtD
Lisinopril—Chest pain—Carmustine—melanoma	0.000507	0.00164	CcSEcCtD
Lisinopril—Anxiety—Carmustine—melanoma	0.000505	0.00164	CcSEcCtD
Lisinopril—Cough—Temozolomide—melanoma	0.000502	0.00163	CcSEcCtD
Lisinopril—Paraesthesia—Bleomycin—melanoma	0.0005	0.00162	CcSEcCtD
Lisinopril—Weight increased—Docetaxel—melanoma	0.0005	0.00162	CcSEcCtD
Lisinopril—Weight decreased—Docetaxel—melanoma	0.000497	0.00161	CcSEcCtD
Lisinopril—Dyspnoea—Bleomycin—melanoma	0.000496	0.00161	CcSEcCtD
Lisinopril—Anorexia—Dactinomycin—melanoma	0.000495	0.0016	CcSEcCtD
Lisinopril—Pneumonia—Docetaxel—melanoma	0.000492	0.0016	CcSEcCtD
Lisinopril—Confusional state—Carmustine—melanoma	0.00049	0.00159	CcSEcCtD
Lisinopril—Arthralgia—Temozolomide—melanoma	0.00049	0.00159	CcSEcCtD
Lisinopril—Myalgia—Temozolomide—melanoma	0.00049	0.00159	CcSEcCtD
Lisinopril—Anxiety—Temozolomide—melanoma	0.000488	0.00158	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—RPS3—melanoma	0.000487	0.0115	CbGpPWpGaD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000486	0.00158	CcSEcCtD
Lisinopril—Oedema—Carmustine—melanoma	0.000486	0.00158	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000485	0.00157	CcSEcCtD
Lisinopril—Discomfort—Temozolomide—melanoma	0.000484	0.00157	CcSEcCtD
Lisinopril—Decreased appetite—Bleomycin—melanoma	0.000484	0.00157	CcSEcCtD
Lisinopril—Infection—Carmustine—melanoma	0.000483	0.00157	CcSEcCtD
Lisinopril—Acute coronary syndrome—Docetaxel—melanoma	0.000482	0.00156	CcSEcCtD
Lisinopril—Renal failure—Docetaxel—melanoma	0.000481	0.00156	CcSEcCtD
Lisinopril—Myocardial infarction—Docetaxel—melanoma	0.00048	0.00156	CcSEcCtD
Lisinopril—Neuropathy peripheral—Docetaxel—melanoma	0.00048	0.00156	CcSEcCtD
Lisinopril—Dry mouth—Temozolomide—melanoma	0.000479	0.00155	CcSEcCtD
Lisinopril—Jaundice—Docetaxel—melanoma	0.000477	0.00155	CcSEcCtD
Lisinopril—Nateglinide—PPARG—melanoma	0.000477	0.0297	CrCbGaD
Lisinopril—Pain—Bleomycin—melanoma	0.000476	0.00154	CcSEcCtD
Lisinopril—Thrombocytopenia—Carmustine—melanoma	0.000476	0.00154	CcSEcCtD
Lisinopril—Tachycardia—Carmustine—melanoma	0.000474	0.00154	CcSEcCtD
Lisinopril—Confusional state—Temozolomide—melanoma	0.000473	0.00154	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000473	0.00153	CcSEcCtD
Lisinopril—Oedema—Temozolomide—melanoma	0.000469	0.00152	CcSEcCtD
Lisinopril—Anaphylactic shock—Temozolomide—melanoma	0.000469	0.00152	CcSEcCtD
Lisinopril—Infection—Temozolomide—melanoma	0.000466	0.00151	CcSEcCtD
Lisinopril—Anorexia—Carmustine—melanoma	0.000463	0.0015	CcSEcCtD
Lisinopril—Hepatobiliary disease—Docetaxel—melanoma	0.000463	0.0015	CcSEcCtD
Lisinopril—Epistaxis—Docetaxel—melanoma	0.000462	0.0015	CcSEcCtD
Lisinopril—Thrombocytopenia—Temozolomide—melanoma	0.00046	0.00149	CcSEcCtD
Lisinopril—Feeling abnormal—Bleomycin—melanoma	0.000459	0.00149	CcSEcCtD
Lisinopril—Agranulocytosis—Docetaxel—melanoma	0.000457	0.00148	CcSEcCtD
Lisinopril—Skin disorder—Temozolomide—melanoma	0.000456	0.00148	CcSEcCtD
Lisinopril—Hypotension—Carmustine—melanoma	0.000454	0.00147	CcSEcCtD
Lisinopril—Hyperhidrosis—Temozolomide—melanoma	0.000454	0.00147	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—ADAMTS20—melanoma	0.000453	0.0107	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PIGU—melanoma	0.000453	0.0107	CbGpPWpGaD
Lisinopril—Decreased appetite—Dactinomycin—melanoma	0.000451	0.00146	CcSEcCtD
Lisinopril—Fatigue—Dactinomycin—melanoma	0.000447	0.00145	CcSEcCtD
Lisinopril—Anorexia—Temozolomide—melanoma	0.000447	0.00145	CcSEcCtD
Lisinopril—Pain—Dactinomycin—melanoma	0.000444	0.00144	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Carmustine—melanoma	0.000443	0.00144	CcSEcCtD
Lisinopril—Urticaria—Bleomycin—melanoma	0.000442	0.00143	CcSEcCtD
Lisinopril—Rhinitis—Docetaxel—melanoma	0.00044	0.00143	CcSEcCtD
Lisinopril—Body temperature increased—Bleomycin—melanoma	0.00044	0.00143	CcSEcCtD
Lisinopril—Hepatitis—Docetaxel—melanoma	0.000439	0.00143	CcSEcCtD
Lisinopril—Insomnia—Carmustine—melanoma	0.000439	0.00142	CcSEcCtD
Lisinopril—Paraesthesia—Carmustine—melanoma	0.000436	0.00141	CcSEcCtD
Lisinopril—Pharyngitis—Docetaxel—melanoma	0.000436	0.00141	CcSEcCtD
Lisinopril—Urinary tract disorder—Docetaxel—melanoma	0.000434	0.00141	CcSEcCtD
Lisinopril—Dyspnoea—Carmustine—melanoma	0.000433	0.0014	CcSEcCtD
Lisinopril—Oedema peripheral—Docetaxel—melanoma	0.000433	0.0014	CcSEcCtD
Lisinopril—Somnolence—Carmustine—melanoma	0.000432	0.0014	CcSEcCtD
Lisinopril—Urethral disorder—Docetaxel—melanoma	0.000431	0.0014	CcSEcCtD
Lisinopril—Feeling abnormal—Dactinomycin—melanoma	0.000428	0.00139	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Temozolomide—melanoma	0.000428	0.00139	CcSEcCtD
Lisinopril—Insomnia—Temozolomide—melanoma	0.000425	0.00138	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dactinomycin—melanoma	0.000424	0.00138	CcSEcCtD
Lisinopril—Decreased appetite—Carmustine—melanoma	0.000422	0.00137	CcSEcCtD
Lisinopril—Paraesthesia—Temozolomide—melanoma	0.000421	0.00137	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Carmustine—melanoma	0.000419	0.00136	CcSEcCtD
Lisinopril—Dyspnoea—Temozolomide—melanoma	0.000418	0.00136	CcSEcCtD
Lisinopril—Somnolence—Temozolomide—melanoma	0.000417	0.00135	CcSEcCtD
Lisinopril—Erythema multiforme—Docetaxel—melanoma	0.000415	0.00135	CcSEcCtD
Lisinopril—Pain—Carmustine—melanoma	0.000415	0.00135	CcSEcCtD
Lisinopril—Constipation—Carmustine—melanoma	0.000415	0.00135	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—ARL2—melanoma	0.000414	0.00978	CbGpPWpGaD
Lisinopril—Dyspepsia—Temozolomide—melanoma	0.000413	0.00134	CcSEcCtD
Lisinopril—Body temperature increased—Dactinomycin—melanoma	0.00041	0.00133	CcSEcCtD
Lisinopril—Abdominal pain—Dactinomycin—melanoma	0.00041	0.00133	CcSEcCtD
Lisinopril—Hypersensitivity—Bleomycin—melanoma	0.00041	0.00133	CcSEcCtD
Lisinopril—Decreased appetite—Temozolomide—melanoma	0.000408	0.00132	CcSEcCtD
Lisinopril—Flushing—Docetaxel—melanoma	0.000408	0.00132	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Temozolomide—melanoma	0.000405	0.00131	CcSEcCtD
Lisinopril—Fatigue—Temozolomide—melanoma	0.000405	0.00131	CcSEcCtD
Lisinopril—Constipation—Temozolomide—melanoma	0.000401	0.0013	CcSEcCtD
Lisinopril—Pain—Temozolomide—melanoma	0.000401	0.0013	CcSEcCtD
Lisinopril—Feeling abnormal—Carmustine—melanoma	0.0004	0.0013	CcSEcCtD
Lisinopril—Asthenia—Bleomycin—melanoma	0.000399	0.00129	CcSEcCtD
Lisinopril—Angiopathy—Docetaxel—melanoma	0.000399	0.00129	CcSEcCtD
Lisinopril—Gastrointestinal pain—Carmustine—melanoma	0.000397	0.00129	CcSEcCtD
Lisinopril—Mediastinal disorder—Docetaxel—melanoma	0.000396	0.00128	CcSEcCtD
Lisinopril—Chills—Docetaxel—melanoma	0.000394	0.00128	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.000394	0.0093	CbGpPWpGaD
Lisinopril—Pruritus—Bleomycin—melanoma	0.000394	0.00128	CcSEcCtD
Lisinopril—Arrhythmia—Docetaxel—melanoma	0.000393	0.00127	CcSEcCtD
Lisinopril—Alopecia—Docetaxel—melanoma	0.000388	0.00126	CcSEcCtD
Lisinopril—Feeling abnormal—Temozolomide—melanoma	0.000387	0.00125	CcSEcCtD
Lisinopril—Mental disorder—Docetaxel—melanoma	0.000385	0.00125	CcSEcCtD
Lisinopril—Body temperature increased—Carmustine—melanoma	0.000384	0.00125	CcSEcCtD
Lisinopril—Abdominal pain—Carmustine—melanoma	0.000384	0.00125	CcSEcCtD
Lisinopril—Gastrointestinal pain—Temozolomide—melanoma	0.000384	0.00124	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ARNT—melanoma	0.000384	0.00906	CbGpPWpGaD
Lisinopril—Malnutrition—Docetaxel—melanoma	0.000382	0.00124	CcSEcCtD
Lisinopril—Erythema—Docetaxel—melanoma	0.000382	0.00124	CcSEcCtD
Lisinopril—Hypersensitivity—Dactinomycin—melanoma	0.000382	0.00124	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000381	0.00899	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.000379	0.00895	CbGpPWpGaD
Lisinopril—ABCB1—lymph node—melanoma	0.000379	0.00481	CbGeAlD
Lisinopril—Dysgeusia—Docetaxel—melanoma	0.000375	0.00121	CcSEcCtD
Lisinopril—Urticaria—Temozolomide—melanoma	0.000373	0.00121	CcSEcCtD
Lisinopril—Asthenia—Dactinomycin—melanoma	0.000372	0.00121	CcSEcCtD
Lisinopril—Body temperature increased—Temozolomide—melanoma	0.000371	0.0012	CcSEcCtD
Lisinopril—Abdominal pain—Temozolomide—melanoma	0.000371	0.0012	CcSEcCtD
Lisinopril—Back pain—Docetaxel—melanoma	0.00037	0.0012	CcSEcCtD
Lisinopril—Muscle spasms—Docetaxel—melanoma	0.000368	0.00119	CcSEcCtD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000359	0.00847	CbGpPWpGaD
Lisinopril—Hypersensitivity—Carmustine—melanoma	0.000358	0.00116	CcSEcCtD
Lisinopril—Diarrhoea—Dactinomycin—melanoma	0.000355	0.00115	CcSEcCtD
Lisinopril—Vomiting—Bleomycin—melanoma	0.000354	0.00115	CcSEcCtD
Lisinopril—Anaemia—Docetaxel—melanoma	0.000354	0.00115	CcSEcCtD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000352	0.00832	CbGpPWpGaD
Lisinopril—Rash—Bleomycin—melanoma	0.000351	0.00114	CcSEcCtD
Lisinopril—Dermatitis—Bleomycin—melanoma	0.000351	0.00114	CcSEcCtD
Lisinopril—Asthenia—Carmustine—melanoma	0.000348	0.00113	CcSEcCtD
Lisinopril—Hypersensitivity—Temozolomide—melanoma	0.000346	0.00112	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.000344	0.00813	CbGpPWpGaD
Lisinopril—Syncope—Docetaxel—melanoma	0.000343	0.00111	CcSEcCtD
Lisinopril—Leukopenia—Docetaxel—melanoma	0.000342	0.00111	CcSEcCtD
Lisinopril—Cilazapril—ABCB1—melanoma	0.000341	0.0213	CrCbGaD
Lisinopril—Palpitations—Docetaxel—melanoma	0.000338	0.0011	CcSEcCtD
Lisinopril—Asthenia—Temozolomide—melanoma	0.000337	0.00109	CcSEcCtD
Lisinopril—Loss of consciousness—Docetaxel—melanoma	0.000336	0.00109	CcSEcCtD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—melanoma	0.000335	0.0079	CbGpPWpGaD
Lisinopril—Cough—Docetaxel—melanoma	0.000334	0.00108	CcSEcCtD
Lisinopril—Diarrhoea—Carmustine—melanoma	0.000332	0.00108	CcSEcCtD
Lisinopril—Pruritus—Temozolomide—melanoma	0.000332	0.00108	CcSEcCtD
Lisinopril—Nausea—Bleomycin—melanoma	0.000331	0.00107	CcSEcCtD
Lisinopril—Vomiting—Dactinomycin—melanoma	0.00033	0.00107	CcSEcCtD
Lisinopril—Rash—Dactinomycin—melanoma	0.000327	0.00106	CcSEcCtD
Lisinopril—Chest pain—Docetaxel—melanoma	0.000326	0.00106	CcSEcCtD
Lisinopril—Myalgia—Docetaxel—melanoma	0.000326	0.00106	CcSEcCtD
Lisinopril—Arthralgia—Docetaxel—melanoma	0.000326	0.00106	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000323	0.00105	CcSEcCtD
Lisinopril—Dizziness—Carmustine—melanoma	0.000321	0.00104	CcSEcCtD
Lisinopril—Diarrhoea—Temozolomide—melanoma	0.000321	0.00104	CcSEcCtD
Lisinopril—Dry mouth—Docetaxel—melanoma	0.000318	0.00103	CcSEcCtD
Lisinopril—Confusional state—Docetaxel—melanoma	0.000315	0.00102	CcSEcCtD
Lisinopril—Anaphylactic shock—Docetaxel—melanoma	0.000312	0.00101	CcSEcCtD
Lisinopril—Oedema—Docetaxel—melanoma	0.000312	0.00101	CcSEcCtD
Lisinopril—ACE2—Metabolism of proteins—PAX6—melanoma	0.000311	0.00734	CbGpPWpGaD
Lisinopril—Dizziness—Temozolomide—melanoma	0.00031	0.00101	CcSEcCtD
Lisinopril—Infection—Docetaxel—melanoma	0.00031	0.00101	CcSEcCtD
Lisinopril—Vomiting—Carmustine—melanoma	0.000309	0.001	CcSEcCtD
Lisinopril—Nausea—Dactinomycin—melanoma	0.000308	0.001	CcSEcCtD
Lisinopril—Shock—Docetaxel—melanoma	0.000307	0.000996	CcSEcCtD
Lisinopril—Rash—Carmustine—melanoma	0.000306	0.000993	CcSEcCtD
Lisinopril—Dermatitis—Carmustine—melanoma	0.000306	0.000992	CcSEcCtD
Lisinopril—Thrombocytopenia—Docetaxel—melanoma	0.000306	0.000991	CcSEcCtD
Lisinopril—Tachycardia—Docetaxel—melanoma	0.000305	0.000988	CcSEcCtD
Lisinopril—Headache—Carmustine—melanoma	0.000304	0.000987	CcSEcCtD
Lisinopril—Skin disorder—Docetaxel—melanoma	0.000303	0.000983	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—SLC17A5—melanoma	0.000302	0.00714	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—HSPA5—melanoma	0.000299	0.00705	CbGpPWpGaD
Lisinopril—Vomiting—Temozolomide—melanoma	0.000298	0.000968	CcSEcCtD
Lisinopril—Anorexia—Docetaxel—melanoma	0.000298	0.000965	CcSEcCtD
Lisinopril—Rash—Temozolomide—melanoma	0.000296	0.00096	CcSEcCtD
Lisinopril—Dermatitis—Temozolomide—melanoma	0.000296	0.000959	CcSEcCtD
Lisinopril—Headache—Temozolomide—melanoma	0.000294	0.000954	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—ADAMTS13—melanoma	0.000292	0.00689	CbGpPWpGaD
Lisinopril—Hypotension—Docetaxel—melanoma	0.000292	0.000946	CcSEcCtD
Lisinopril—Nausea—Carmustine—melanoma	0.000289	0.000936	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Docetaxel—melanoma	0.000284	0.000922	CcSEcCtD
Lisinopril—Insomnia—Docetaxel—melanoma	0.000282	0.000916	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	0.000281	0.00663	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	0.000281	0.00663	CbGpPWpGaD
Lisinopril—Paraesthesia—Docetaxel—melanoma	0.00028	0.000909	CcSEcCtD
Lisinopril—Nausea—Temozolomide—melanoma	0.000279	0.000904	CcSEcCtD
Lisinopril—Dyspnoea—Docetaxel—melanoma	0.000278	0.000903	CcSEcCtD
Lisinopril—Somnolence—Docetaxel—melanoma	0.000278	0.0009	CcSEcCtD
Lisinopril—Dyspepsia—Docetaxel—melanoma	0.000275	0.000891	CcSEcCtD
Lisinopril—Decreased appetite—Docetaxel—melanoma	0.000271	0.00088	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Docetaxel—melanoma	0.000269	0.000874	CcSEcCtD
Lisinopril—Fatigue—Docetaxel—melanoma	0.000269	0.000873	CcSEcCtD
Lisinopril—Constipation—Docetaxel—melanoma	0.000267	0.000866	CcSEcCtD
Lisinopril—Pain—Docetaxel—melanoma	0.000267	0.000866	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000264	0.00623	CbGpPWpGaD
Lisinopril—Feeling abnormal—Docetaxel—melanoma	0.000257	0.000834	CcSEcCtD
Lisinopril—Gastrointestinal pain—Docetaxel—melanoma	0.000255	0.000828	CcSEcCtD
Lisinopril—Enalapril—ABCB1—melanoma	0.000251	0.0156	CrCbGaD
Lisinopril—ACE—Peptide hormone metabolism—CTNNB1—melanoma	0.000248	0.00586	CbGpPWpGaD
Lisinopril—Abdominal pain—Docetaxel—melanoma	0.000247	0.0008	CcSEcCtD
Lisinopril—Body temperature increased—Docetaxel—melanoma	0.000247	0.0008	CcSEcCtD
Lisinopril—Hypersensitivity—Docetaxel—melanoma	0.00023	0.000746	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	0.00023	0.00542	CbGpPWpGaD
Lisinopril—Asthenia—Docetaxel—melanoma	0.000224	0.000726	CcSEcCtD
Lisinopril—Pruritus—Docetaxel—melanoma	0.000221	0.000716	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—RPS3—melanoma	0.000218	0.00514	CbGpPWpGaD
Lisinopril—Diarrhoea—Docetaxel—melanoma	0.000214	0.000693	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	0.000212	0.00501	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	0.00021	0.00496	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	0.000209	0.00494	CbGpPWpGaD
Lisinopril—Dizziness—Docetaxel—melanoma	0.000206	0.00067	CcSEcCtD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000206	0.00487	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.0002	0.00472	CbGpPWpGaD
Lisinopril—Vomiting—Docetaxel—melanoma	0.000198	0.000644	CcSEcCtD
Lisinopril—Rash—Docetaxel—melanoma	0.000197	0.000638	CcSEcCtD
Lisinopril—Dermatitis—Docetaxel—melanoma	0.000197	0.000638	CcSEcCtD
Lisinopril—Headache—Docetaxel—melanoma	0.000196	0.000634	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000193	0.00455	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FOXP3—melanoma	0.000191	0.00451	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	0.00019	0.00448	CbGpPWpGaD
Lisinopril—Nausea—Docetaxel—melanoma	0.000185	0.000601	CcSEcCtD
Lisinopril—Nateglinide—ALB—melanoma	0.000179	0.0112	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—MMP1—melanoma	0.000177	0.00418	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000175	0.00413	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	0.000167	0.00394	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000157	0.00372	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	0.000156	0.00368	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.000149	0.00352	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000144	0.00339	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000143	0.00338	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—melanoma	0.000141	0.00334	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PAX6—melanoma	0.000139	0.00328	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP2—melanoma	0.000137	0.00323	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—HSPA5—melanoma	0.000133	0.00315	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CTLA4—melanoma	0.000131	0.0031	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000129	0.00304	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.00012	0.00283	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	0.000119	0.00282	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CXCL8—melanoma	0.000114	0.00268	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	0.000111	0.00262	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.000107	0.00253	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.000107	0.00253	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CTNNB1—melanoma	0.000105	0.00248	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD86—melanoma	0.000104	0.00246	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	0.000104	0.00245	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—melanoma	0.000102	0.00241	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	9.94e-05	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL4—melanoma	9.94e-05	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	9.89e-05	0.00233	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—PDGFRA—melanoma	9.78e-05	0.00231	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-B—melanoma	9.72e-05	0.00229	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	9.6e-05	0.00227	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FASLG—melanoma	9.5e-05	0.00224	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FAS—melanoma	9.16e-05	0.00216	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	9.1e-05	0.00215	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	9.04e-05	0.00214	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-A—melanoma	9e-05	0.00213	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	8.93e-05	0.00211	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	8.23e-05	0.00194	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	8e-05	0.00189	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	7.99e-05	0.00189	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP1—melanoma	7.9e-05	0.00186	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD80—melanoma	7.6e-05	0.00179	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	7.51e-05	0.00177	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP8—melanoma	7.07e-05	0.00167	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	6.77e-05	0.0016	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	6.51e-05	0.00154	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—IGF1—melanoma	6.32e-05	0.00149	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	6.12e-05	0.00144	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MMP2—melanoma	6.11e-05	0.00144	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	6.1e-05	0.00144	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IFNG—melanoma	6.01e-05	0.00142	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	5.91e-05	0.0014	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL8—melanoma	5.59e-05	0.00132	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CASP3—melanoma	5.35e-05	0.00126	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL2—melanoma	5.34e-05	0.00126	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	5.32e-05	0.00125	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	5.24e-05	0.00124	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CXCL8—melanoma	5.08e-05	0.0012	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	4.99e-05	0.00118	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	4.88e-05	0.00115	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.83e-05	0.00114	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.78e-05	0.00113	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	4.69e-05	0.00111	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—CTNNB1—melanoma	4.69e-05	0.00111	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	4.6e-05	0.00109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACER3—melanoma	4.57e-05	0.00108	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—melanoma	4.54e-05	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	4.52e-05	0.00107	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	4.43e-05	0.00105	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	4.21e-05	0.000993	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UGT2B10—melanoma	4.18e-05	0.000987	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	3.99e-05	0.000943	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	3.98e-05	0.000939	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—melanoma	3.89e-05	0.000918	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HS3ST5—melanoma	3.89e-05	0.000918	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	3.82e-05	0.000901	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.74e-05	0.000884	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.7e-05	0.000874	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	3.49e-05	0.000823	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	3.43e-05	0.000809	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	3.34e-05	0.000789	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	3.31e-05	0.000782	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	3.15e-05	0.000744	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.99e-05	0.000706	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.95e-05	0.000696	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLCB4—melanoma	2.95e-05	0.000696	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.91e-05	0.000686	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.84e-05	0.000671	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC6A11—melanoma	2.77e-05	0.000654	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIP4K2A—melanoma	2.77e-05	0.000654	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.7e-05	0.000638	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTAP—melanoma	2.69e-05	0.000636	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.69e-05	0.000636	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.64e-05	0.000623	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.57e-05	0.000606	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.54e-05	0.0006	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.48e-05	0.000587	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.48e-05	0.000585	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.47e-05	0.000582	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PHGDH—melanoma	2.4e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LUM—melanoma	2.4e-05	0.000567	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HPSE—melanoma	2.36e-05	0.000556	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CUBN—melanoma	2.31e-05	0.000546	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.24e-05	0.000529	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SDHD—melanoma	2.23e-05	0.000527	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BSG—melanoma	2.23e-05	0.000527	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CSPG4—melanoma	2.23e-05	0.000527	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPAM—melanoma	2.16e-05	0.00051	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.12e-05	0.0005	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.06e-05	0.000486	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.02e-05	0.000476	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.01e-05	0.000476	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.92e-05	0.000453	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.9e-05	0.000449	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PLA2G6—melanoma	1.84e-05	0.000434	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.75e-05	0.000413	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.69e-05	0.000399	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—VCAN—melanoma	1.65e-05	0.00039	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.43e-05	0.000337	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP17A1—melanoma	1.39e-05	0.000329	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNA11—melanoma	1.32e-05	0.000311	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.29e-05	0.000305	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—FASN—melanoma	1.29e-05	0.000304	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A5—melanoma	1.27e-05	0.000299	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNAQ—melanoma	1.22e-05	0.000289	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD44—melanoma	1.22e-05	0.000289	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1B1—melanoma	1.17e-05	0.000277	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PRKCA—melanoma	8.89e-06	0.00021	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ERCC2—melanoma	8.82e-06	0.000208	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CG—melanoma	6.96e-06	0.000164	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—melanoma	6.72e-06	0.000159	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CD—melanoma	6.12e-06	0.000144	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—melanoma	6.04e-06	0.000143	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CB—melanoma	5.33e-06	0.000126	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—melanoma	5.29e-06	0.000125	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTEN—melanoma	4.61e-06	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3CA—melanoma	3.25e-06	7.68e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—melanoma	2.66e-06	6.27e-05	CbGpPWpGaD
